Literature DB >> 19918714

Inhibitory activity of a phytochemically characterized fraction from Streptocaulon juventas on lung cancer in nude mice.

Na Han1, Jingyu Yang, Linwei Li, Bin Xiao, Sha Sha, Lequan Tran, Jun Yin, Chunfu Wu.   

Abstract

In the present study, a 75% ethanol extract of Streptocaulon juventas (SJ), which had a strong inhibitory effect on the proliferation of human lung A549 adenocarcinoma cells, was subjected to bioassay-guided fractionation. The most active fraction (SJF) was obtained using a macroreticular resin column followed by a silica-gel column. Then its in vivo effect on lung cancer was investigated in athymic nude mice with A549 tumors while its effects on body weight, blood biochemical indicators, and organ indices were monitored. The results showed that SJF inhibited the tumor growth significantly at day 10 and day 15 during treatment without physical side effects. Following HPLC and NMR spectrometry, the main components of SJF were identified as digitoxigenin, periplogenin, and periplogenin glucoside. Georg Thieme Verlag KG Stuttgart.New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918714     DOI: 10.1055/s-0029-1240600

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.

Authors:  Yamei Hu; Fangfang Liu; Xuechao Jia; Penglei Wang; Tingxuan Gu; Hui Liu; Tingting Liu; Huifang Wei; Hanyong Chen; Jiuzhou Zhao; Ran Yang; Yingying Chen; Zigang Dong; Kangdong Liu
Journal:  Oncogene       Date:  2021-05-13       Impact factor: 9.867

2.  Chemical characterization and assessment of antioxidant potentiality of Streptocaulon sylvestre Wight, an endangered plant of sub-Himalayan plains of West Bengal and Sikkim.

Authors:  Priyankar Dey; Sandipan Ray; Mousumi Poddar Sarkar; Tapas Kumar Chaudhuri
Journal:  BMC Complement Altern Med       Date:  2015-04-08       Impact factor: 3.659

Review 3.  Evaluating the cancer therapeutic potential of cardiac glycosides.

Authors:  José Manuel Calderón-Montaño; Estefanía Burgos-Morón; Manuel Luis Orta; Dolores Maldonado-Navas; Irene García-Domínguez; Miguel López-Lázaro
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.